Guest guest Posted June 30, 2000 Report Share Posted June 30, 2000 AstraZeneca Plc said its new ZD4522 heart drug reduced elevated low-density lipoprotein cholesterol levels by up to 65% in clinical trials. http://chemweb.com/alchem/2000/news/nw_000630_astra.html Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.